Correction: Beneficial bacteria inhibit cachexia

Bernard J. Varian; Sravya Gourishetti; Theofilos Poutahidis; Jessica R. Lakritz; Tatiana Levkovich; Caitlin Kwok; Konstantinos Teliousis; Yassin M. Ibrahim; Sheyla Mirabal; Susan E. Erdman

doi:10.18632/oncotarget.25750

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Beneficial bacteria inhibit cachexia

PDF | How to cite

Oncotarget. 2018; 9:29536-29536. https://doi.org/10.18632/oncotarget.25750

Metrics: PDF 1776 views | ?

Bernard J. Varian¹, Sravya Gourishetti¹, Theofilos Poutahidis^1,2, Jessica R. Lakritz¹, Tatiana Levkovich¹, Caitlin Kwok¹, Konstantinos Teliousis², Yassin M. Ibrahim¹, Sheyla Mirabal¹ and Susan E. Erdman¹

¹ Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA, USA
² Laboratory of Pathology, Faculty of Veterinary Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

Published: June 29, 2018

This article has been corrected: The corrected author name is given below:

Sravya Gourishetti

Original article: 2016; 7:11803-11816. DOI: https://doi.org/10.18632/oncotarget.7730.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25750

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: Beneficial bacteria inhibit cachexia